Gray area for new heart failure drug. Although the FDA approved BiDil for blacks with heart failure, it may work in anyone
- PMID: 16363036
Item in Clipboard
Gray area for new heart failure drug. Although the FDA approved BiDil for blacks with heart failure, it may work in anyone
Harv Heart Lett.
2005 Nov.
No abstract available
Similar articles
-
Bidil: recontextualizing the race debate.Pharmacogenomics J. 2008 Jun;8(3):169-73. doi: 10.1038/sj.tpj.6500489. Epub 2008 Jan 15. Pharmacogenomics J. 2008. PMID: 18195727 No abstract available.
-
BiDil for heart failure in black patients.Ann Intern Med. 2007 Aug 7;147(3):215; author reply 215-6. doi: 10.7326/0003-4819-147-3-200708070-00019. Ann Intern Med. 2007. PMID: 17679713 No abstract available.
-
BiDil for heart failure in black patients.Ann Intern Med. 2007 Aug 7;147(3):214-5; author reply 215-6. doi: 10.7326/0003-4819-147-3-200708070-00018. Ann Intern Med. 2007. PMID: 17679712 No abstract available.
-
BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.Cardiol Rev. 2007 Jan-Feb;15(1):46-53. doi: 10.1097/01.crd.0000250840.15645.fb. Cardiol Rev. 2007. PMID: 17172884 Review.
-
Genotyping the future: scientists' expectations about race/ ethnicity after BiDil.J Law Med Ethics. 2008 Fall;36(3):464-70. doi: 10.1111/j.1748-720X.2008.292.x. J Law Med Ethics. 2008. PMID: 18840237 Review.
Cited by
-
A brave old world: an analysis of scientific racism and BiDil.Mcgill J Med. 2006 Jan;9(1):54-60. Mcgill J Med. 2006. PMID: 19529811 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical